Thoratec Corporation HeartMate PHP™ Cardiogenic Shock Trial

计划入组 9 人 · 首次发布于 2014 年 10 月 31 日

KT(KT Corporation)-SNUBH(Seoul National University Bundang Hospital) U-health Cooperative Research

计划入组 60 人 · 首次发布于 2015 年 3 月 11 日

Efficacy of the Erchonia Corporation THL™ for Providing Relief of Tinnitus Symptoms

计划入组 23 人 · 首次发布于 2022 年 5 月 16 日

Sabin mOPV2(Fidec Corporation)

MKCC1106-MT(Mannkind Corporation)

Lassa vaccine (Etubics Corporation)

Cambrex Charles City, Inc.

United States

CAMBREX PROFARMACO MILANO SRL

Italy

Cambrex Charles City Inc

Sweden

US Small Molecule API CDMO Market Projected to Reach $12.49 Billion by 2030 Driven by FDA Approvals and HPAPI Demand

Small Molecule API Market to Reach $370.36 Billion by 2035, Driven by Oncology Demand and Manufacturing Innovation

Cambrex Expands Peptide Manufacturing Capabilities with 20% Facility Growth in Massachusetts